Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies.
about
Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy.Characterization of PD-1 upregulation on tumor-infiltrating lymphocytes in human and murine gliomas and preclinical therapeutic blockade.Immune Checkpoint Inhibitors in Gliomas.Correlation of immune phenotype with IDH mutation in diffuse glioma.Tumor Vaccines for Malignant Gliomas.Angiogenesis inhibitors in tackling recurrent glioblastoma.EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise.In search of a target: PD-1 and PD-L1 profiling across glioma types.Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas.PD-1 related transcriptome profile and clinical outcome in diffuse gliomas.Preclinical investigation of combined gene-mediated cytotoxic immunotherapy and immune checkpoint blockade in glioblastoma.ID(H)entifying checkpoint inhibitor candidates among diffuse glioma.Assessment of PD-1 positive cells on initial and secondary resected tumor specimens of newly diagnosed glioblastoma and its implications on patient outcome.Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastoma.Immune Microenvironment in Glioblastoma Subtypes.
P2860
Q37741143-0C430F38-9B92-4BC3-9392-AA50054DEEB3Q38691679-B006F049-1D76-4FBB-95C4-ACCBD8FCAC9CQ38743793-BE5EE687-60A0-487E-B908-036D8BBF633CQ38771020-DBE77AF0-747E-4A25-9503-A868746ACC2CQ39228039-F5581156-04C9-4697-8A5A-C2AD5AB6E03BQ39259089-2A9F6795-E9C4-4FE5-A73E-AC17093E45F3Q40089704-CB007A71-3C23-4A1F-B8AC-6C9AEF3E028BQ42391407-199B1F90-76FD-47BC-B0AD-C58BC4DDF7B8Q47126110-BA121B96-F8DA-4A77-9AEA-259C208E6FDFQ47199921-354C4430-24AB-4EE8-AF57-E20879952411Q47827127-0579672D-C674-42CA-884C-746F01F4FFDFQ50074883-11C0217B-78BC-42A5-9847-89F965E7A6B0Q52097229-39C05385-0046-4DA3-A449-860516819490Q52733768-D07234B7-9A98-4E13-9E96-B5C7FB374B99Q55261256-5C71BF99-083A-44AF-AB2A-FCB69F488DA3
P2860
Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies.
@en
type
label
Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies.
@en
prefLabel
Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies.
@en
P2093
P2860
P356
P1433
P1476
Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies.
@en
P2093
Amy B Heimberger
David Spetzler
Joanne Xiu
John de Groot
Roel G W Verhaak
Sandeep K Reddy
Sarah T Garber
Shiao-Pei Weathers
Shouhao Zhou
Yuuri Hashimoto
P2860
P304
P356
10.1093/NEUONC/NOW132
P577
2016-07-01T00:00:00Z